cinchocaine
| Price | USD10.00 |
| Packge | 1KG |
- Min. Order:1KG
- Supply Ability:20Tons/WEEK
- Time:2021-07-09
Product Details
- Product Namecinchocaine
- CAS No.85-79-0
- EINECS No.201-632-1
- MFC20H29N3O2
- MW343.46
- AppearanceSolid:particulate/powderWhite to yellow
- Melting point 64°
- Boiling point 478.73°C (rough estimate)
- density 1.1145 (rough estimate)
- Water Solubility 68.01mg/L(temperature not stated)
- storage temp. Store at -20°C
Product Description
| Product Name | Dibucaine |
| Synonyms | Dibucaine Base;Nupercainal;Dibucain;Nupercaine;Dermacaine; Cinchocaine;Cinchocainum;dibucaine;2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide;dibucaine hydrochloride;Dibucaine;Sovcaine;Cincocainio; |
| CAS No. | 85-79-0 |
| Molecular Formula | C20H29N3O2 |
| Molecular Weight | 343.46 |
| EINECS No. | 201-632-1 |
| Melting point | 64° |
| Boiling point | 229.5 °C766 mm Hg(lit.) |
| Flash point | 209 °F |
| Density | 1.026 g/mL at 25 °C(lit.) |
| Refractive index | n20/D 1.501(lit.) |
| Appearance | White Powder |
| Purity | 99% |
Dibucaine is a local anesthetic of the amide type now generally used for surface anesthesia.Target: Sodium ChannelDibucaine is an amide local anesthetic. Dibucaine reduced the degradation of BSA-gold complex in the reservosomes, which was not caused either by an inhibition of the whole proteolytic activity of the parasite or by a reduction on the expression levels of cruzipain.Dibucaine, a quaternary ammonium compound, inhibited SChE to a minimum within 2 min in a reversible manner. The inhibition was very potent. It had an IC(50) of 5.3 microM with BuTch or 3.8 microM with AcTch. The inhibition was competitive with respect to BuTch with a K(i) of 1.3 microM and a linear-mixed type (competitive/noncompetitive) with respect to AcTch with inhibition constants, K(i) and K(I) of 0.66 and 2.5 microM, respectively. Dibucaine possesses a butoxy side chain that is similar to the butryl group of BuTch and longer by an ethylene group from AcTch.
Related Products
| Product name | CAS |
| 4-Piperidone monohydrate hydrochloride | 40064-34-4 |
| N-BOC-4-piperidone | 79099-07-3 |
| benzyl 4-oxopiperidine-1-carboxylate | 19099-07-3 |
| 2-bromo-1-phenylpentan-1-one | 49851-31-2 |
| 2-Iodo-1-(4-methylphenyl)-1-propanone | 236117-38-7 |
| 2-iodo-1-phenyl-pentane-1-one | 124878-55-3 |
| ethyl 3-oxo-2-phenylbutanoate | 5413-05-8 |
| N-(2-benzoyl-4-nitrophenyl)-2-bromoacetamide | 2011-70-3 |
| Tetracaine hydrochloride | 136-47-0 |
| tert-Butyl 4-anilinotetrahydro-1(2H)-pyridinecarboxylate | 125541-22-2 |
| 4-Amino-3,5-dichloroacetophenone | 37148-48-4 |
| 4-Amino-3,5-dichlorophenacylbromide | 37148-47-3 |
| 2,5-Dimethoxybenzaldehyde | 93-02-7 |
| tetracaine | 94-24-6 |
| 4-methylpropiophenone | 5337-93-9 |
| Xylazine hydrochloride | 23076-35-9 |
| 1-Phenyl-2-nitropropene | 705-60-2 |
| 2-Bromo-4'-Methylpropiophenone | 1451-82-7 |
| 2-(benzylamino)-2-methylpropan-1-ol | 10250-27-8 |
| benzocaine | 94-09-7 |
| (2-Bromoethyl)benzene | 103-63-9 |
| lidocaine | 137-58-6 |
| lidocaine hydrochloride | 73-78-9 |
| ethyl 4-aminobenzoate,hydrochloride | 23239-88-5 |
| 4-methoxybenzoic acid | 100-09-4 |
| valerophenone | 1009-14-9 |
| N-Benzylisopropylamine | 102-97-6 |
| Methyl 3-(benzo[d][1,3]dioxol-5-yl)-2-methyloxirane-2-carboxylate | 13605-48-6 |
| lead diacetate trihydrate | 6080-56-4 |
| N-methylformamide | 123-39-7 |
| methylamine hydrochloride | 593-51-1 |
| Hydroxychloroquine sulfate | 747-36-4 |
Company Profile Introduction
- Since:2019-07-05
- Address: Federation business plaza, qiaoxi district, shijiazhuang city, hebei province
